New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 25, 2013
06:33 EDTIMGNImmunoGen says T-DM1 marketing application under review in U.S, Europe
ImmunoGen expects to reports clinical findings for three compounds and expects to advance its fourth compound, IMGN289, into clinical testing.
News For IMGN From The Last 14 Days
Check below for free stories on IMGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 15, 2014
10:28 EDTIMGNHigh option volume stocks
High option volume stocks: TRGT ALB UUP ADHD ROC WWW CTRL KERX IMGN NI
10:08 EDTIMGNImmunoGen receives orphan status for ovarian cancer treatment
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use